These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4151883)

  • 41. On the reversal by (plus) and (minus)-propranolol of irreversible alpha-adrenoceptor blockade in rabbit aorta.
    Janis RA; Triggle DJ
    Pharmacol Res Commun; 1974 Feb; 6(1):55-60. PubMed ID: 4154460
    [No Abstract]   [Full Text] [Related]  

  • 42. Development of tolerance to the inhibitory effects of ethanol in the isolated rat vas deferens. Effect of selective agonists and antagonists.
    DeTurck KH; Pohorecky LA
    Pharmacology; 1987; 34(6):337-47. PubMed ID: 3659119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenergic stimulation of phosphatidylinositol labelling in rat vas deferens.
    Canessa de Scarnati O; Lapetina EG
    Biochim Biophys Acta; 1974 Sep; 360(3):298-305. PubMed ID: 4369760
    [No Abstract]   [Full Text] [Related]  

  • 44. Phenoxybenzamine blockade of the enhancing effect of substance P on the twitch induced by transmural nerve stimulation in the guinea pig vas deferens.
    von Euler US; Hedqvist P
    Acta Physiol Scand; 1974 Oct; 92(2):283-5. PubMed ID: 4473012
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and adrenergic neuron blocking properties of some alkylating analogues of bretylium.
    Krueger CA; Cook DA
    Arch Int Pharmacodyn Ther; 1975 Nov; 218(1):96-105. PubMed ID: 1212016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-adrenergic receptors in coronary and skeletal muscle arteries.
    Baron GD; Speden RN; Bohr DF
    Am J Physiol; 1972 Oct; 223(4):878-81. PubMed ID: 4403874
    [No Abstract]   [Full Text] [Related]  

  • 47. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
    Suzuki E; Tsujimoto G; Tamura K; Hashimoto K
    Mol Pharmacol; 1990 Nov; 38(5):725-36. PubMed ID: 1978244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Catecholamine release: mechanism of mercury-induced vascular smooth muscle contraction.
    Solomon HS; Hollenberg NK
    Am J Physiol; 1975 Jul; 229(1):8-12. PubMed ID: 238407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships in 1,4-benzodioxan-related compounds. 4. Effect of aryl and alkyl substituents at position 3 on alpha-adrenoreceptor blocking activity.
    Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Marucci G; Melchiorre C
    J Med Chem; 1993 May; 36(11):1520-8. PubMed ID: 8098772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and alpha-adrenolytic activity of chiral beta-haloethylamines.
    Riley TN; Crawford FW
    J Pharm Sci; 1976 Apr; 65(4):544-7. PubMed ID: 5589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional effects of castration on alpha1-adrenoceptors in rat vas deferens.
    Pupo AS
    Eur J Pharmacol; 1998 Jun; 351(2):217-23. PubMed ID: 9687006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
    Hicks PE; Langer SZ; Macrae AD
    Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperthyroid induced changes in adrenergic receptor status in guinea pig vas deferens.
    Ahuja GB; Goyal RK; Verma SC
    Indian J Exp Biol; 1983 May; 21(5):272-4. PubMed ID: 6667979
    [No Abstract]   [Full Text] [Related]  

  • 55. A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens.
    Henderson G; Hughes J; Kosterlitz HW
    Br J Pharmacol; 1972 Dec; 46(4):764-6. PubMed ID: 4655272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationships in 1,4-benzodioxan-related compounds. 2. Role of the amine function on alpha-adrenoreceptor blocking activity.
    Giardinà D; Gulini U; Pigini M; Piloni MG; Melchiorre C
    Farmaco; 1990 Dec; 45(12):1289-98. PubMed ID: 1982488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.
    Noamesi BK; Bamgbose SO
    Planta Med; 1980 May; 39(1):51-6. PubMed ID: 6105685
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: Induced receptors for noradrenaline and serotonin in guinea-pig vas deferens.
    Reiffenstein RJ; Woytiuk E
    Br J Pharmacol; 1975 Oct; 55(2):302P. PubMed ID: 1201427
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence against adrenergic motor transmission in the guinea-pig vas deferens.
    Ambache N; Zar MA
    J Physiol; 1971 Jul; 216(2):359-89. PubMed ID: 4397760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.